Last reviewed · How we verify
NCT05080400: WIGG
White Rice and Effect of Gellan Gum on Glucose Responses by MRI
NA trial testing White rice in Glycemic Response to Feeding in Healthy Participants in 12 participants. Completed in 22 November 2021.
27 October 2021
Quick facts
| Lead sponsor | University of Nottingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 14 July 2021 |
| Primary completion | 27 October 2021 |
| Estimated completion | 22 November 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- White rice
- Gellan gum
Conditions studied
- Glycemic Response to Feeding in Healthy Participants — all drugs for Glycemic Response to Feeding in Healthy Participants →
Sponsor
University of Nottingham
Who can join
Adults 18 to 65, any sex, with Glycemic Response to Feeding in Healthy Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rice is a staple food for over half the world's population. High consumption of white rice has been linked with high obesity and increased risk for type 2 diabetes. However, it is still the favoured type of rice among consumers, contributing to the observed increasing trends in diet-related diseases in countries with high rice consumption. Controlling the properties of white rice products (e.g. reducing the glycaemic index and/or increasing satiety) with relatively simple interventions could contribute to producing foods with health-promoting digestibility profiles. One way to reduce the glycaemic index of white rice is through processing. Addition of food thickeners (called hydrocolloid gums) has previously been shown to reduce the digestibility of foods. This work will test the hypothesis that gellan gum is a simple way to manipulate the body's glucose response to a white rice which in turn will have health-promoting effects. MRI imaging will be used to monitor the gastrointestinal responses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05080400
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of White rice
Trials testing the same drug.
- NCT05713227 — White Rice and Gellan Gum 7 Days Intervention · NA · completed
- NCT06560541 — Rice Intervention in Chronic Health Study · NA · completed
- NCT03630458 — Digestive Properties of Carbohydrate-based Foods · NA · completed
- NCT03362151 — A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Bloo · NA · completed
Other recruiting trials for Glycemic Response to Feeding in Healthy Participants
Currently open trials in the same condition.
- NCT06874400 — Comparison of Dairy and Plant-based Alternatives in Adolescents and Older Adults · NA · recruiting
Other University of Nottingham trials
Trials by the same sponsor.
- NCT07518381 — Medication Understanding in MS · not yet recruiting
- NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
- NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05080400 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
- Last refreshed: 29 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05080400.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing